Benitec Biopharma stock price

NASDAQ:BNTC · Nasdaq · Healthcare · sector #16
$8.50-5.97%Oct 21 close · provisional
Loading chart…

Benitec Biopharma's chart data is dated 2026-10-21. Recorded technical signals: RSI rebound, MACD bullish cross. There are 2 published signal records.

Benitec Biopharma last closed at $8.50 (-5.97%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -9.2×. Its overall grade ranks 122 of 726 stocks in Healthcare.

About this company

Benitec Biopharma last closed at $8.50 (-5.97%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall A · 122/726

Valuation grade A+

Details →

Related stocks

  • Astellas PharmaCustomer
  • CureDuchenneCustomer
  • Duchenne muscular dystrophyRelated theme
Details →
About Benitec Biopharma
What technical signals does Benitec Biopharma (BNTC) have?
Benitec Biopharma current technical signals: RSI rebound, MACD bullish cross.
Is Benitec Biopharma a cup-and-handle pattern?
No. Benitec Biopharma has no valid Cup signal right now.
What published figures are available for Benitec Biopharma?
Market cap: $217.6M. Trailing 12 months PER: -9.2×. Latest quarter PBR: 2.38×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Turn what you saw on this name into a strategy

Ask Q about Benitec Biopharma, or open the plan table on the main site.

Ask Q about Benitec Biopharma.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Benitec Biopharma notifications

Quantus Signal · live data · not investment advice · Privacy Policy